2 assets in Neoplasm Of Neck

Therapeutic assets addressing Neoplasm Of Neck, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cis-Diamminedichloroplatinum Ii Neoplasm Of Neck	Loren Mell, MD	P2	CCC (53)
Pembrolizumab Neoplasm Of Neck	Loren Mell, MD	P2	CCC (53)